Rani Therapeutics, LLC Wed, Jun 21, 2023, 8:00 AM4 min read ...

The data will be presented today, May 8, 2024, from 3:00 p.m. – 3:15 p.m. ET at ASGCT in an oral presentation entitled “Development of an In Vivo Non-Viral Ocular Editing Platform and ...

Announced strategic research collaboration with Chugai for two undisclosed molecules – – Presented preclinical data ...

Presentation Details: Title: "Use of lucicebtide (ST101) in glioblastoma patients by antagonism of C/EBPβ-dependent mesenchymal cell transition and immunosuppressive M2 macrophage polarization" ...

Provided by PR NewswireJun 1, 2025, 1:39:00 AM ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein ...

The data will be presented in an oral session at the Muscular Dystrophy Association (MDA) 2025 Clinical and Scientific Conference taking place on March 16-19 in Dallas, Texas.

Oral Presentations: The final oral presentation schedule will be available on the website by Friday, July 25, 2025. Scheduling will occur in 15-minute increments, grouped with presentations from the ...